SCLX•benzinga•
Scilex Announces Approval Of New Drug Submission From Health Canada's Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy And Neurological Sciences For ELYXYB's Acute Treatment of Migraine With or Without Aura In Canada
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 15, 2025 by benzinga